H S Pathology Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.20 M
- Company Age 14 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.00 M
About H S Pathology
H S Pathology Private Limited (HSPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 07 May 2010 and has a history of 14 years and nine months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.20 M.
The company has closed loans amounting to ₹1.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Deepak Abhayakumar and Abhaya Mayur serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74990TN2010PTC169600
- Company No.
202832
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 May 2010
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at H S Pathology?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhaya Mayur  | Director | 05-Sep-2022 | Current |
| Deepak Abhayakumar | Director | 20-Aug-2024 | Current |
Financial Performance of H S Pathology.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of H S Pathology?
Unlock access to H S Pathology's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Venkata Narayana Active Ingredients Private LimitedDeepak Abhayakumar is a mutual person
Novocura Tech Health Services Private LimitedAbhaya Mayur is a mutual person
Spovum Technologies Private LimitedAbhaya Mayur is a mutual person
Dhanvantari Nano Ayushadi Private LimitedDeepak Abhayakumar is a mutual person
Supath Healthcare Services Private LimitedAbhaya Mayur is a mutual person
Cellutions Biostorage Private LimitedDeepak Abhayakumar and Abhaya Mayur are mutual person
Charges (Loans)
₹0
₹1.00 M
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Oct 2013 | Indian Overseas Bank | ₹1.00 M | Satisfied |
How Many Employees Work at H S Pathology?
Unlock and access historical data on people associated with H S Pathology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of H S Pathology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped H S Pathology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
